ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013